Imidazodiazepine derivatives for treatment of disorders of the c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540498, 540493, 514220, A61K 3133, C07D48702

Patent

active

048639206

ABSTRACT:
A compound for treating disorders of the central nervous system, which is of the formula
wherein A taken together with the two carbon atoms denoted by .alpha. and .beta. is one of the following groups: ##STR1## R.sup.1 is one of the following groups:

REFERENCES:
patent: 4280957 (1981-07-01), Walser et al.
patent: 4316839 (1982-02-01), Gerecke et al.
patent: 4352818 (1982-10-01), Hunkeler et al.
patent: 4775671 (1988-10-01), Hunkeler et al.
J. March, "Advanced Organic Chemistry: Reaction Mechanisms and Structure", McGraw-Hill Book Co., New York (1968).
Morrison and Boyd, "Organic Chemistry" (1976).
Hendrickson et al., "Organic Chemistry", 3d. Edition, McGraw-Hill, Kogakusha, Tokyo (1970).
Litter, "Pharmacology", 6th Edition, El Ateneo, Buenos Aires (1980).
Goodman and Gilman, "The Pharmacological Basis of Therapeutics", 6th Edition, MacMillan & Co. (1980).
The Merck Index, 10th Edition (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazodiazepine derivatives for treatment of disorders of the c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazodiazepine derivatives for treatment of disorders of the c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazodiazepine derivatives for treatment of disorders of the c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-243616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.